Read + Share
Bruzzese A, Assanto GM, Diverio D, Quattrocchi L, et al. Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single
center experience. Bone Marrow Transplant 2021;56:1455-1457.
PMID: 33514926
|
 |
|
Bruzzese A, Assanto GM, Diverio D, Quattrocchi L, et al. Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single
center experience. Bone Marrow Transplant 2021;56:1455-1457.
PMID: 33514926
|
|
|
|